Main > OBESITY. (**) > USA. E. GIP/GLP1 CoAgonist Inj.

---

USA. E. GIP/GLP1 CoAgonist Inj.'s subsections
(*) USA Approval Date: 2023. 11.08
Company
Generic Name
PR Web-Site
TM
USA Patent Number

USA. E. GIP/GLP1 CoAgonist Inj.'s products
This section has no products